A significant milestone in early pharmaceutical development is the selection of the lead solid form. This step can be tricky, however, because about 90% of organic molecules have multiple forms. But problems at this stage can spell trouble down the line for drug candidates’ manufacturability, stability and bioavailability. Because many smaller drug developments don’t have…